A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
Clinical trial NCT06592768 · TERMINATED
Trial details
- NCT number
- NCT06592768
- Sponsor
- Jasper Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-26
- Primary completion
- 2025-08-11
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.